Innate Pharma SA (IPHA) Current Reports & Earnings Releases
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-08-19 | 6-K | — | SEC |
| 2026-08-14 | 6-K | — | SEC |
| 2026-08-10 | 6-K | — | SEC |
| 2026-07-23 | 6-K | — | SEC |
| 2026-07-21 | 6-K | — | SEC |
| 2026-05-22 | 6-K | — | SEC |
| 2026-05-19 | 6-K | — | SEC |
| 2026-05-13 | 6-K | — | SEC |
| 2026-05-12 | 6-K | — | SEC |
| 2026-05-06 | 6-K | — | SEC |
| 2026-04-23 | 6-K | — | SEC |
| 2026-04-17 | 6-K | — | SEC |
| 2026-04-13 | 6-K | — | SEC |
| 2026-04-13 | 6-K | — | SEC |
| 2026-04-08 | 6-K | — | SEC |
| 2026-04-03 | 6-K | — | SEC |
| 2026-04-02 | 6-K | — | SEC |
| 2026-03-26 | 6-K | — | SEC |
| 2026-03-19 | 6-K | — | SEC |
| 2026-02-18 | 6-K | — | SEC |
| 2026-01-07 | 6-K | — | SEC |
| 2025-12-22 | 6-K | — | SEC |
| 2025-12-11 | 6-K | — | SEC |
| 2025-11-28 | 6-K | — | SEC |
| 2025-11-17 | 6-K | — | SEC |
| 2025-11-13 | 6-K | — | SEC |
| 2025-11-10 | 6-K | — | SEC |
| 2025-11-05 | 6-K | — | SEC |
| 2025-10-15 | 6-K | — | SEC |
| 2025-09-17 | 6-K | — | SEC |
| 2025-09-17 | 6-K | — | SEC |
| 2025-09-15 | 6-K | — | SEC |
| 2025-09-10 | 6-K | — | SEC |
| 2025-09-02 | 6-K | — | SEC |
| 2025-08-04 | 6-K | — | SEC |
| 2025-07-29 | 6-K | — | SEC |
| 2025-07-07 | 6-K | — | SEC |
| 2025-06-17 | 6-K | — | SEC |
| 2025-06-13 | 6-K | — | SEC |
| 2025-05-27 | 6-K | — | SEC |
| 2025-05-23 | 6-K | — | SEC |
| 2025-05-23 | 6-K | — | SEC |
| 2025-05-19 | 6-K | — | SEC |
| 2025-05-15 | 6-K | — | SEC |
| 2025-05-13 | 6-K | — | SEC |
| 2025-05-12 | 6-K | — | SEC |
| 2025-05-06 | 6-K | — | SEC |
| 2025-04-30 | 6-K | — | SEC |
| 2025-04-29 | 6-K | — | SEC |
| 2025-04-28 | 6-K | — | SEC |
| 2025-04-24 | 6-K | — | SEC |
| 2025-04-23 | 6-K | — | SEC |
| 2025-04-16 | 6-K | — | SEC |
| 2025-04-16 | 6-K | — | SEC |
| 2025-04-03 | 6-K | — | SEC |
| 2025-03-27 | 6-K | — | SEC |
| 2025-03-26 | 6-K | — | SEC |
| 2025-03-25 | 6-K | — | SEC |
| 2025-03-20 | 6-K | — | SEC |
| 2025-02-27 | 6-K | — | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.